Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 401 - 420 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »
Reset 

Prelude and Loyal: Collaborating to Extend Canine Lifespans

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024

AMERICAN SKIN ASSOCIATION EARNS CANDID'S 2024 PLATINUM SEAL OF TRANSPARENCY AND CHARITY NAVIGATOR'S FOUR-STAR RATING

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024

FDA Roundup: April 19, 2024

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024
Related companies:  U.S. Food and Drug Administration

Grifols 2023 Annual Report on Form 20-F filed with the SEC

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024
Related companies:  Grifols USA, LLC | Grifols Biologicals Inc. | Grifols Therapeutics, Inc.

NCPDP's National Facilitator Model Pilot Project Enters Second Phase

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024

Vayiz Unveils PTLC - Mark 1: Revolutionizing Medical Diagnostics with Pioneering AI Technology

Read more ››
By: PR Newswire Association LLC. - 19 Apr 2024

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Alvotech

ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  ProQR Therapeutics NV

Tiziana Life Sciences Announces Study Results from Intranasal Anti-CD3 Foralumab in Multiple Sclerosis Patients with PIRA Highlighted in Neurology Today®

Read more ››
By: GlobeNewswire - 19 Apr 2024

Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2 ArMaDa Clinical Trial of OCU410—A Modifier Gene Therapy

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Ocugen, Inc.

Preliminary Results for the Year Ended 31 December 2023

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Biodexa Pharmaceuticals PLC

NeuroMetrix Announces Steps Taken to Enhance Shareholder Value

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  NeuroMetrix, Inc.

3Daughters Named “Startup of the Year” at BioLabs Philadelphia Investor Day 2024

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  3Daughters

VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023

Read more ››
By: GlobeNewswire - 19 Apr 2024

CorMedix Inc. Announces CMS Grants TDAPA to DefenCath

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  CorMedix Inc.

Lifeward Announces the Appointment of Mike Swinford to its Board of Directors

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  ReWalk Robotics Ltd.

PharmAla Closes Private Placement and Concurrent Debt Settlement

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  PharmAla Biotech

TScan Therapeutics Announces Closing of Upsized Public Offering

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  TScan Therapeutics, Inc.

Dr. Sam Barrell CBE appointed as CEO of LifeArc

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  LifeArc | LifeArc Centre for Therapeutics Discovery (CTD) | LifeArc Ventures

Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024

Read more ››
By: GlobeNewswire - 19 Apr 2024
Related companies:  Zealand Pharma A/S
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 21  22  23  24  25 »
to the top ↑